Skip to main content
. 2020 Oct 6;100(17):5627. doi: 10.2340/00015555-3363

Table I.

Baseline characteristics of patients with vasculitis

HV n = 21 IgA vasculitis n = 22 UV n = 22 EED n = 3 PAN n = 4 p-value*
Age, years, mean ± SD 39.4 ± 22.4 27.9 ± 25.5 46.8 ± 16.1 23.3 ± 21.8 31 ± 9.0 IgA vs. UV 0.018, LCV vs. IgA 0.226, LCV vs. UV 0.506
Age, years, median 43 16 45 19 31.5
Sex, n (%)a
 Male 13 (61.9) 12 (54.5) 2 (9.1) 1 (33.3) 1 (25) UV vs. LCV 0.000 and UV vs. IgA 0.000
 Female 8 (38.1) 8 (36.4) 20 (90.9) 2 (66.7) 3 (75) UV vs. LCV 0.000 and UV vs. IgA 0.000
Duration, n (%)a
 < 1 week 5 (26.3) 6 (27.3) 1 (4.5) 0 (0) 0 (0)
 1–4 weeks 7 (36.8) 10 (45.5) 3 (13.6) 0 (0) 1 (25)
 1–6 months 4 (21.1) 2 (9.1) 7 (31.8) 0 (0) 1 (25)
 > 6 months 3 (15.8) 2 (9.1) 11 (50) 3 (100) 2 (50)
Direct immunofluorescence, n (%)
 C3 5 (23.8) 7 (31.8) 0.558
 IgG 1 (4.8) 3 (13.6) 0.317
 IgM 4 (19) 5 (22.7) 0.767
 IgA 0 (0) 22 (100) 0.000
 Fibrinogen 6 (28.6) 2 (10.0) 0.101
 0 7 (33.3) 0 (0) 0.001
Systemic involvement, n (%) 7 (33.3) 16 (80) 0.003
 Joint involvement 4 (19) 9 (45) 0.074
 Renal
 Nephrotic range proteinuria 2 (9.5) 4 (20) 0.343
 Haematuria 3 (14.3) 2 (10.0) 0.675
 Gastrointestinal
 Abdominal pain 3 (14.3) 8 (40) 0.063
 Haematochezia 2 (9.5) 4 (20) 0.343
Aetiology, n (%)
 Idiopathic 6 (28.6) 8 (40) 0.440
 Infection 6 (28.6) 7 (35) 0.658
 Drug 5 (23.8) 5 (20) 0.768
 Malignancy 1 (4.8) 0 (0) 0.323
 Autoimmune 3 (14.3) 1 (5) 0.317
a

2 missing (9.1).

*

p-value for difference between groups by x2 test for proportions, 1-way analysis of variance (ANOVA) for continuous variables and Kruskal–Wallis 1-way ANOVA for ordinal variables

SD: standard deviation; HV: hypersensitivity vasculitis; UV: urticarial vasculitis; EED: erythema elevatum diutinum; PAN: polyarteritis nodosa; LCV: leukocytoclastic vasculitis.